Work

Phase I/II Trial of rBPI-21 (a Recombinant 21kD Fragment of Bactericidal/Permeability-Increasing Protein) in Children with Severe Meningococcemia.

Year: 1997

Type: conference-abstract

Source: Shock

DOI: 10.1097/00024382-199703001-00577

Authors: E. Kirsch, P. Quint, S. Carroll, P. Scannon, B. Giroir

Institutions: Randall Children's Hospital at Legacy Emanuel, XOMA (United States), The University of Texas Southwestern Medical Center

Language: English

Topic: Bacterial Infections and Vaccines

Subfield: Microbiology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2313016699

Cites:

Cited by: 2

Related to: 10